Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Matching mutations in tumours to precision medicine improves survival

Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA
Matching mutations in tumours to precision medicine improves survival ( Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA )
2 Jun 2018

Editor’s Choice for May 2018

Prof Gordon McVie - Founding Editor, ecancer
Editor’s Choice for May 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
21 May 2018

Incorporating biomarkers into clinical trial design

Dr Amar Gajjar - St. Jude Children's Research Hospital, Memphis, USA
Incorporating biomarkers into clinical trial design ( Dr Amar Gajjar - St. Jude Children's Research Hospital, Memphis, USA )
11 May 2018

Clinical management of plasma cell leukaemia

Dr Francesca Gay - University of Torino, Torino, Italy
Clinical management of plasma cell leukaemia ( Dr Francesca Gay - University of Torino, Torino, Italy )
2 May 2018

Dose escalation of durvalumab with tremelimumab for metastatic urothelial cancer

Dr Arjun Balar - NYU Langone Medical Center, New York, USA
Dose escalation of durvalumab with tremelimumab for metastatic urothelial cancer ( Dr Arjun Balar - NYU Langone Medical Center, New York, USA )
25 Apr 2018

Biomarkers of pembrolizumab response in head and neck cancer

Dr Tanguy Seiwert - The University of Chicago Medicine, Chicago, USA
Biomarkers of pembrolizumab response in head and neck cancer ( Dr Tanguy Seiwert - The University of Chicago Medicine, Chicago, USA )
25 Apr 2018

Safety indications in mouse models treated with full doses of MEK inhibitors and SHP099

Dr Carmine Fedele - Laura and Isaac Perlmutter Cancer Center at New York University Langone Medical, New York, USA
Safety indications in mouse models treated with full doses of MEK inhibitors and SHP099 ( Dr Carmine Fedele - Laura and Isaac Perlmutter Cancer Center at New York University Langone Medical, New York, USA )
25 Apr 2018

Mechanisms and prospects of a novel CDK9 inhibitor for DLBCL

Dr Susan Galbraith - AstraZeneca, Cambridge, UK
Mechanisms and prospects of a novel CDK9 inhibitor for DLBCL ( Dr Susan Galbraith - AstraZeneca, Cambridge, UK )
25 Apr 2018

Front-line therapy of DIPG using IDO inhibitor with radiation and chemotherapy

Dr Theodore Johnson - Georgia Cancer Center, Augusta, USA
Front-line therapy of DIPG using IDO inhibitor with radiation and chemotherapy ( Dr Theodore Johnson - Georgia Cancer Center, Augusta, USA )
25 Apr 2018

Impact of microbiome on head and neck cancers

Dr Young Jun Kim - Vanderbilt-Ingram Cancer Center, Nashville, USA
Impact of microbiome on head and neck cancers ( Dr Young Jun Kim - Vanderbilt-Ingram Cancer Center, Nashville, USA )
25 Apr 2018

First-in-human trial results of RET targeted BLU-667

Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA
First-in-human trial results of RET targeted BLU-667 ( Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA )
25 Apr 2018

Treating RET alterations with novel therapy BLU-667

Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA
Treating RET alterations with novel therapy BLU-667 ( Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA )
25 Apr 2018